OLAPARIB: A promising PARP Inhibitor for the treatment of ovarian cancer
By:
Language: English
Page range: 1 - 7
Submitted on: Sep 18, 2015
Accepted on: Sep 30, 2015
Published on: Dec 17, 2015
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2015 Nikolaos Soupos, Konstantinos Laschos, Evangelos Bournakis, Euthymios Kostouros, Gerasimos Aravantinos, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.